These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 31196609)

  • 61. Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors.
    Guo W; Li H; Li Y; Kong W
    Biomed Pharmacother; 2023 Sep; 165():115025. PubMed ID: 37385209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.
    Aboolian A; Urner S; Roden M; Jha JC; Jandeleit-Dahm K
    Handb Exp Pharmacol; 2022; 274():269-307. PubMed ID: 35318511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Narrative Review of Diabetic Kidney Disease: Previous and Current Evidence-Based Therapeutic Approaches.
    Mima A
    Adv Ther; 2022 Aug; 39(8):3488-3500. PubMed ID: 35751762
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiological characteristics of diabetic kidney disease in Taiwan.
    Wang JS; Yen FS; Lin KD; Shin SJ; Hsu YH; Hsu CC;
    J Diabetes Investig; 2021 Dec; 12(12):2112-2123. PubMed ID: 34529360
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel biomarkers for prognosticating diabetic kidney disease progression.
    Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
    Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.
    Duan S; Lu F; Song D; Zhang C; Zhang B; Xing C; Yuan Y
    Front Endocrinol (Lausanne); 2021; 12():661185. PubMed ID: 34177803
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives.
    Tanase DM; Gosav EM; Anton MI; Floria M; Seritean Isac PN; Hurjui LL; Tarniceriu CC; Costea CF; Ciocoiu M; Rezus C
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.
    González-Pérez A; Saez M; Vizcaya D; Lind M; Garcia Rodriguez L
    BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34607828
    [TBL] [Abstract][Full Text] [Related]  

  • 69. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
    Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease.
    Li S; Zheng S; Li J; Lin S; Li H; Wang P; Chen P; Ma C; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1257430. PubMed ID: 37732129
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease.
    Shaffner J; Chen B; Malhotra DK; Dworkin LD; Gong R
    Front Endocrinol (Lausanne); 2021; 12():749010. PubMed ID: 34790170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy.
    Wang Y; Zhao H; Wang Q; Zhou X; Lu X; Liu T; Zhan Y; Li P
    J Diabetes Res; 2019; 2019():9030893. PubMed ID: 31828168
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
    Ao L; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modes of podocyte death in diabetic kidney disease: an update.
    Jiang A; Song A; Zhang C
    J Nephrol; 2022 Jul; 35(6):1571-1584. PubMed ID: 35201595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
    Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
    Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
    Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
    J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Research progress on the role of ET-1 in diabetic kidney disease.
    Zhang S; Li X; Liu S; Zhang W; Li M; Qiao C
    J Cell Physiol; 2023 Jun; 238(6):1183-1192. PubMed ID: 37063089
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.